Novavax
Novavax develops protein-based nanoparticle vaccines using its Matrix-M adjuvant technology platform.
10-KSep 28Latest SEC filing
Aug 6Latest story
August 2026
Sign inSign inNovavax develops protein-based nanoparticle vaccines using its Matrix-M adjuvant technology platform.